LMRINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Lumexa Imaging Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$10.72−0.06 (-0.56%)
Close on Oct 19, 2026
- Market cap
- $1.03B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$7.81 (−42.15%)since Dec 12, 2025
Weekly closes, adjusted for splits, on a log scale. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $1.03B
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.67
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Book value per share
- $6.40
- Diluted shares
- 96M
Two years at a glance
Fiscal years 2024 to 2025, USD
Reported period